Patient Derived Xenograft/PDX Models Market Worth 167.6 Million USD by 2022
The report "Patient Derived Xenograft/PDX Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) - Global Forecast to 2022", The PDX models market is expected to reach USD 167.6 Million by 2022 from an estimated USD 77.4 Million in 2017, at a CAGR of 16.7%. The key factors driving the growth of this market include the growing demand for personalized medicine, continuous support for...
View full press release